PTU-055 Safety and tolerability of combination therapy for chronic hepatitis C: the Leeds experience

IntroductionCombination therapy is the mainstay of treatment for chronic hepatitis C (CHC). However, some patients report debilitating adverse events (AEs), which may limit efficacy due to need for dose reduction or discontinuation of therapy. We report tolerability and safety of combination therapy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2010-04, Vol.59 (Suppl 1), p.A71
Hauptverfasser:	Ford, A C, Sheridan, S A, Wigglesworth, C M, Rehman, J, Aldersley, M A, Davies, M H, Millson, C E, Jones, R L
Format:	Artikel
Sprache:	eng
Schlagworte:	Alopecia Cirrhosis Demography Genotypes Hepatitis Hepatitis C Interferon Liver cirrhosis Multivariate analysis Nausea Patients Sepsis Skin Sleep disorders Thyroid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!